Condition: Cervical Intraepithelial Neoplasia · Sponsor: Barretos Cancer Hospital
Cervical cancer remains the first or second leading cause of cancer death among women in many low-and middle-income countries. Cervical cancer prevention programs in low-resource settings are hampered by a lack of personnel with appropriate clinical expertise, lack of pathology services, and lack of associated infrastructure. There is an urgent need for appropriate diagnostic tools to enable accurate screening and diagnosis in low-resource settings. The purpose of this study is to develop and validate a low-cost Multimodal Mobile Colposcope (MMC) for global cervical cancer prevention programs. This new device will combine the imaging capabilities of a mobile colposcope with the microscopic imaging capabilities of a fiber-optic confocal imaging probe.
This description comes directly from the study's public registry record.
Júlio César P Resende, MD, PhD · +55 (17) 3321-6600 · julio.possati@uol.com.br
Mila P Salcedo, MD, PhD · +1-832-316-3774 · mpsalcedo@mdanderson.org
Always discuss trial participation with your own doctor first.
| Irmandade Santa Casa de Misericórdia de Porto Alegre | Porto Alegre, Rio Grande do Sul, Brazil | Recruiting |
| Barretos Cancer Hospital | Barretos, São Paulo, Brazil | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05078528